[{"address1": "631 US Hwy 1", "address2": "Suite 407", "city": "North Palm Beach", "state": "FL", "zip": "33408", "country": "United States", "phone": "612 961 5656", "website": "https://www.nascentbiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean  Carrick", "age": 55, "title": "President, CEO, Secretary & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lowell  Holden", "age": 80, "title": "CFO, Chief Accounting Officer & Director", "yearBorn": 1943, "fiscalYear": 2023, "totalPay": 180000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark C. Glassy Ph.D.", "age": 71, "title": "Founder", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 43000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Navpaul  Singh M.D.", "title": "Chief Medical Consultant", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0889, "open": 0.0765, "dayLow": 0.07, "dayHigh": 0.0765, "regularMarketPreviousClose": 0.0889, "regularMarketOpen": 0.0765, "regularMarketDayLow": 0.07, "regularMarketDayHigh": 0.0765, "volume": 70890, "regularMarketVolume": 70890, "averageVolume": 64657, "averageVolume10days": 41312, "averageDailyVolume10Day": 41312, "bid": 0.07, "ask": 0.08, "marketCap": 11881100, "fiftyTwoWeekLow": 0.0413, "fiftyTwoWeekHigh": 0.28, "fiftyDayAverage": 0.0940568, "twoHundredDayAverage": 0.13295315, "currency": "USD", "enterpriseValue": 11691972, "floatShares": 94425576, "sharesOutstanding": 169730000, "heldPercentInsiders": 0.39998, "heldPercentInstitutions": 0.0063099996, "bookValue": -0.002, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -2087682, "trailingEps": -0.01, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "NBIO", "underlyingSymbol": "NBIO", "shortName": "NASCENT BIOTECH INC", "longName": "Nascent Biotech, Inc.", "firstTradeDateEpochUtc": 1259850600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fb6ff19b-671a-32da-890b-5ad7586788ca", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.07, "recommendationKey": "none", "totalCash": 372120, "totalCashPerShare": 0.002, "totalDebt": 122500, "quickRatio": 0.46, "currentRatio": 0.683, "returnOnAssets": -3.45344, "freeCashflow": -1828976, "operatingCashflow": -1186066, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-03"}]